|
[1]
|
Agustí, A, .Celli, B.R., Criner, G.J., et al. (2005) Global Initiative for Chronic Obstructive Lung Disease Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease: An Asia-Pacific Perspective. Respirology, 10, 9-17. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Xu, J., Zeng, Q., Li, S., Su, Q. and Fan, H. (2024) Inflammation Mechanism and Research Progress of COPD. Frontiers in Immunology, 15, Article 1404615. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Hogg, J.C. and Timens, W. (2009) The Pathology of Chronic Obstructive Pulmonary Disease. Annual Review of Pathology: Mechanisms of Disease, 4, 435-459. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Zhou, M., Wang, H., Zeng, X., Yin, P., Zhu, J., Chen, W., et al. (2019) Mortality, Morbidity, and Risk Factors in China and Its Provinces, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet, 394, 1145-1158. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Boers, E., Barrett, M., Su, J.G., Benjafield, A.V., Sinha, S., Kaye, L., et al. (2023) Global Burden of Chronic Obstructive Pulmonary Disease through 2050. JAMA Network Open, 6, e2346598. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Wang, C., Xu, J., Yang, L., Xu, Y., Zhang, X., Bai, C., et al. (2018) Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease in China (the China Pulmonary Health [CPH] Study): A National Cross-Sectional Study. The Lancet, 391, 1706-1717. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Santos, N.C.D., Miravitlles, M., Camelier, A.A., Almeida, V.D.C.D., Maciel, R.R.B.T. and Camelier, F.W.R. (2022) Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review. Tuberculosis and Respiratory Diseases, 85, 205-220. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Maeda, T. and Dransfield, M.T. (2023) Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: Mechanistic Links and Implications for Practice. Current Opinion in Pulmonary Medicine, 30, 141-149. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Barnes, P.J., Burney, P.G.J., Silverman, E.K., Celli, B.R., Vestbo, J., Wedzicha, J.A., et al. (2015) Chronic Obstructive Pulmonary Disease. Nature Reviews Disease Primers, 1, Article No. 15076. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Divo, M., Cote, C., de Torres, J.P., Casanova, C., Marin, J.M., Pinto-Plata, V., et al. (2012) Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 186, 155-161. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Gendarme, S., Maitre, B., Hanash, S., Pairon, J., Canoui-Poitrine, F. and Chouaïd, C. (2024) Beyond Lung Cancer Screening, an Opportunity for Early Detection of Chronic Obstructive Pulmonary Disease and Cardiovascular Diseases. JNCI Cancer Spectrum, 8, pkae082. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Rao, S., Nazarzadeh, M., Li, Y., Canoy, D., Mamouei, M., Salimi-Khorshidi, G., et al. (2023) Systolic Blood Pressure, Chronic Obstructive Pulmonary Disease and Cardiovascular Risk. Heart, 109, 1216-1222. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Li, Y., Li, F., Wang, G., Zeng, Q. and Xie, P. (2025) Additive Impact of Chronic Obstructive Pulmonary Disease (COPD) and Cardiovascular Disease(CVD) on All-Cause and Disease-Specific Mortality: A Longitudinal Nationwide Population-Based Study. BMC Pulmonary Medicine, 25, Article No. 275. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Patel, N. (2024) An Update on COPD Prevention, Diagnosis, and Management. The Nurse Practitioner, 49, 29-36. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Alter, P., Kahnert, K., Trudzinski, F.C., Bals, R., Watz, H., Speicher, T., et al. (2022) Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET. International Journal of Chronic Obstructive Pulmonary Disease, 17, 1703-1713. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Polman, R., Hurst, J.R., Uysal, O.F., Mandal, S., Linz, D. and Simons, S. (2024) Cardiovascular Disease and Risk in COPD: A State of the Art Review. Expert Review of Cardiovascular Therapy, 22, 177-191. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Moll, M., Qiao, D., Regan, E.A., Hunninghake, G.M., Make, B.J., Tal-Singer, R., et al. (2020) Machine Learning and Prediction of All-Cause Mortality in COPD. Chest, 158, 952-964. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Shiroshita, A., Kimura, Y., Shiba, H., Shirakawa, C., Sato, K., Matsushita, S., et al. (2021) Predicting In-Hospital Death in Pneumonic COPD Exacerbation via BAP-65, CURB-65 and Machine Learning. ERJ Open Research, 8, 00452-2021. [Google Scholar] [CrossRef] [PubMed]
|